Aspect Biosystems and JDRF to develop 3D bioprinted treatment for diabetes - 3D Printing Industry

Retrieved on: 2022-04-10 05:19:52

Tags for this article:

Click the tags to see associated articles and topics

Aspect Biosystems and JDRF to develop 3D bioprinted treatment for diabetes - 3D Printing Industry. View article details on hiswai:

Excerpt

3D bioprinting firm Aspect Biosystems is set to work with diabetes research group JDRF to develop a tissue therapy for type 1 diabetics.

Article found on: 3dprintingindustry.com